Richard Pzena's position in Pfizer is currently worth $219 Million. That's 0.80% of their equity portfolio (34th largest holding). The first Pfizer trade was made in Q4 2014. Since then Richard Pzena bought shares seventeen more times and sold shares on eighteen occasions. The investor's estimated purchase price is $251 Million, resulting in a loss of 13%.